Baoshan Wang Dazhou Li Dehua Zeng Wen Wang Chuanshen Jiang
10.3389/fimmu.2023.1086760
Front Immunol
2023 Jan 27;14:1086760.
immunotherapy periampullary primary programmed cell death-ligand 1 sintilimab squamous cell carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36776865/
B7-H1 Antigen / metabolism Carcinoma, Squamous Cell / drug therapy Carcinoma, Squamous Cell / metabolism
B7-H1 Antigen / metabolism Carcinoma, Squamous Cell / drug therapy Carcinoma, Squamous Cell / metabolism Case Reports Research Support, Non-U.S. Gov't Apoptosis Female Humans Immunotherapy Ligands Middle Aged Up-Regulation sintilimab B7-H1 Antigen Ligands
PMC9911421
36776865
Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
2023